Protective effects of gallic acid against chronic cerebral hypoperfusion-induced cognitive deficit and brain oxidative damage in rats by Shahrani, Mehrdad. et al.
Neuropharmacology and analgesia
Protective effects of gallic acid against chronic cerebral
hypoperfusion-induced cognitive deﬁcit and brain oxidative
damage in rats
Mehrdad Shahrani Korani a,b, Yaghoub Farbood a, Alireza Sarkaki a,
Hadi Fathi Moghaddam a, Mohammad Taghi Mansouri c,n
a Dept. of Physiology, Physiology Research Center, School of Medicine, Ahvaz Jundishapur Univ. of Med. Sciences (AJUMS), Ahvaz, Iran
b Medical Plant and Cellular and Molecular Research Centers, School of Medicine, Shahrekord Univ. of Med. Sciences (SUMS), Shahrekord, Iran
c Dept. of Pharmacology, Physiology and Atherosclerosis Research Centers, School of Medicine, Ahvaz Jundishapur Univ. of Med. Sciences (AJUMS), Ahvaz, Iran
a r t i c l e i n f o
Article history:
Received 8 October 2013
Received in revised form
11 March 2014
Accepted 25 March 2014
Available online 12 April 2014
Keywords:
Gallic acid
Permanent cerebral hypoperfusion
Spatial memory
Oxidative stress
Rat
a b s t r a c t
Free radical-induced neural damage is implicated in cerebral hypoperfusion disorders and antioxidants
have protective effects. In the present study, we examined the effect of gallic acid (GA; 100 mg/kg, p.o.
for 10 days) on cognitive deﬁcit and cerebral oxidative stress induced by permanent bilateral common
carotid artery occlusion (2VO) as an animal model of vascular dementia (VD). The results showed that
2VO signiﬁcantly reduced the spatial memory performance in Morris water maze as well as non-
enzymatic (total thiol) and enzymatic [glutathione peroxidase (GPx)] antioxidant contents and increased
the level of malondialdehyde (MDA) in the hippocampus and frontal cortex of vehicle-treated group as
compared to sham-operated rats. Furthermore, chronic administration of GA signiﬁcantly restored the
spatial memory, total thiol and GPx contents and also decreased MDA levels in these tissues. GA alone
did not show any change neither in the status of various antioxidants nor behavioral tests over sham
values. The results demonstrate that GA has beneﬁcial activity against 2VO-induced cognitive deﬁcits via
enhancement of cerebral antioxidant defense. Taken together, the present study suggested that GA
might be useful in the treatment of VD.
& 2014 Elsevier B.V. All rights reserved.
1. Introduction
Ischemic brain injury is caused by the interruption of cerebral
blood ﬂow leading to excessive production of reactive oxygen
species which is associated with behavioral dysfunction and also
cognitive deﬁcits (Li et al., 2011). The formation of reactive oxygen
species represents the ﬁrst key step to initiate tissue oxidative
stress (Silva-Adaya et al., 2008). Oxidative stress is deﬁned as an
imbalance between cellular levels of reactive oxygen species (e.g.,
superoxide and hydroxyl radicals) and cellular antioxidant defense.
Reactive oxygen species are produced by a free radical chain reaction
caused tissue injury by reacting with biomolecules such as lipids,
proteins, and nucleic acids as well as by depleting enzymatic and/or
non-enzymatic antioxidants in the brain. In order to scavenge
reactive oxygen species, various defense systems such as glutathione,
antioxidant enzymes [glutathione peroxidase (GSH-Px), superoxide
dismutase (SOD) and catalase (CAT)] exist in the brain (Akdag et al.,
2010).
Gallic acid (GA, 3,4,5-trihydroxybenzoic acid), is one of the most
important polyphenolic substances in plants which is present in
grapes, different berries, mango, areca nut, walnut, green tea and
other fruits as well as in wine. Also, it is considered as putative active
compound in tannin, namely gallotannin (Singh et al., 2004). This
compound possesses antioxidant, free radical scavenging, anti-can-
cer, anti-inﬂammatory (Bhouri et al., 2012), anti-fungal (Choi et al.,
2010) and anti-human rhinovirus activities (Nguyen et al., 2013).
Gallic acid has also been used in food, cosmetics, and in pharma-
ceuticals as an antioxidant (Bhouri et al., 2012). GA can be used to
treat human albuminuria and diabetes (Hsieh et al., 2007). Moreover,
it has been reported that GA produced anti-anxiety (Dhingra et al.,
2012), anti-depressant (Chhillar and Dhingra, 2013) and anti-
epileptic (Huang et al., 2012) effects in animal models.
Due to the free radical scavenging property, GA-containing
plant extracts have showed anti-diabetic, anti-angiogenic and
anti-melanogenic effects and reduced heart infarction incidence
and the oxidative damage of liver and kidney tissues (Priscilla
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and Prince, 2009). It has been reported that GA is involved in the
protection of neural cells against in vitro β-amyloid peptide (Aβ)-
induced death (Ban et al., 2008). Recently, our research indicated
the neuroprotective effect of GA against cerebral oxidative stress
induced by 6-hydroxydopamine and or streptozotocin in rat brain
(Mansouri et al., 2013a,b). In addition, Ferruzzi et al. (2009)
demonstrated that repeated treatment of rodents with grape seed
extract signiﬁcantly increased the bioavailability and brain deposition
of GA which previously found to attenuate cognitive deterioration in
a mouse model of Alzheimer's disease. Thus, GA as a major constituent
of grape seed extract may be a potential neuroprotective agent.
To the best of our knowledge, there is no published scientiﬁc
report on the protective role of GA against cognitive deﬁcits and
cerebral oxidative stress induced by chronic cerebral hypoperfu-
sion. Therefore, the present study intended to examine the effects
of GA on learning and memory impairments induced by perma-
nent cerebral artery occlusion (2VO) and determined whether this
effect was modulated through antioxidant mechanisms in the
brain.
2. Materials and methods
2.1. Chemicals
DTNB (2,20-dinitro-5,50-dithiodibenzoic acid), TBA (2-thiobar-
bituric acid), n-butanol, tris base, ethylendiamine tetraacetic acid
disodium, sodium acetate, glacial acetic acid, phosphoric acid,
potassium chloride, tetramethoxypropane were obtained from
Merck Company (Darmstadt, Germany) and GA was purchased
from Sigma–Aldrich (St. Louis, MO, USA). All other chemicals were
of analytical grade and prepared from Merck Company (Darm-
stadt, Germany).
2.2. Animals
Adult male Wistar rats weighing 200–250 g were used
throughout the study. All animals were obtained from the Animal
House of Shahrekord Medical School (Shahrekord, Iran). Animals
were allowed free access to standard laboratory chow and water,
ad libitum. A 12-h light/dark cycle at 2272 1C and 50% humidity
conditions were maintained. All procedures were in accordance
with the Guide for the Care and Use of Laboratory Animals
adopted by National Institute of Health and the Federation of
Iranian Societies for Experimental Biology.
2.3. Surgery
Permanent cerebral hypoperfusion (PCH), that mimics the
vascular dementia model, was induced by occlusion of the bilateral
common carotid arteries (two vessels occlusion; 2VO) (Xu et al.,
2012). Brieﬂy, a neck ventral midline incision was made and the
common carotid arteries were then exposed and gently separated
from the vague nerve. The bilateral common carotid arteries were
tied with silk threads, whilst the rats were under an appropriate
level of ketamine/xylazine (50/5 mg/kg) anesthesia (Roohbakhsh
et al., 2007).
2.4. Experimental design
The animals were randomly divided into 4 groups (seven each).
Group 1 was the sham-operated (sham) in which normal saline
(2 ml/kg) was given by oral gavage. Group 2 was 2VO in which
bilateral common carotid artery was ligated and received normal
saline as the same of sham group. Group 3 was shamþGA which
treated with GA at dose of 100 mg/kg (Hsu and Yen, 2007). Group
4 was 2VOþGA in which bilateral common carotid artery was
ligated and received GA at dose of 100 mg/kg. GA administration
was started 5 days before surgery and continued for 10 consecu-
tive days.
2.5. Assessment of spatial memory via Morris water maze test
The spatial memory performance was evaluated using a Morris
water maze (MWM). The water maze used was a black circular tank
(13660, diameterheight) which ﬁlled with water (2071 1C) to
a depth of 25 cm. The maze was located in a room containing extra-
maze cues (posters). The pool geographically divided into four
quadrants [northeast (NE), northwest (NW), southeast (SE), south-
west (SW)] and starting positions [north (N), south (S), east (E),
west (W)] that were equally spaced around the perimeter of the
pool. A hidden circular platform (diameter: 13 cm) was located
2 cm below the surface of the water on a ﬁxed location in one of the
four quadrants of the pool. A video Camera was mounted directly
above the water maze to record the rats’ swim paths. An automated
tracking system (EthoVisions, Noldus, Wageningen, Netherlands)
was used to measure the escape latency and percentage of the time
in the target quadrant. 6 days after 2VO (Kim et al., 2006), rats were
given four training trials each day for 4 consecutive days. For each
training trial, the rats were placed in the water facing the pool wall
at one of the four starting in a different order each day and allowed
to swim until they reached the platform. The latency to reach the
platform was recorded for up to 60 s. The rats remaining on the
platform for 30 s were removed. One day after the last training, a
probe trial was conducted by removing the platform. Rats were
allowed to swim freely into the pool for 60 s. The time spent in the
target quadrant, which had previously contained the hidden plat-
form, was recorded. The time spent in the target quadrant indicated
the degree of memory consolidation that has taken place after
learning. After the trials, the rats were dried with a towel and
placed in a holding cage under a heating lamp before returning to
the home cage. A visible platform trial was performed with the
platform placed on the side of the pool opposite its location during
hidden platform training to check the vision of all rats (Itoh et al.,
1999; Morris, 1984). In order to determine whether the group
differences in escape latency and swimming distance were due to
their differences in swimming ability, the swimming speed was also
evaluated.
2.6. Brain sample collection and biochemical assays
At the end of behavioral experiments, the animals were decapi-
tated and the hippocampus and frontal cortex were removed
quickly, rinsed with saline, and then frozen in a freezer (80 1C)
until used. The tissues were homogenized in cold KCl solution (1.5%)
to give a 10% homogenate suspension used for measuring thiobar-
bituric acid reactive substances value (expressed as malondialde-
hyde (MDA) equivalents), total thiol contents and GSH-Px activity
(Naghizadeh et al., 2008).
2.6.1. Thiobarbituric acid reactive species measurement
MDA levels, an index of lipid peroxidation (LPO), produced by
free radicals were measured. MDA reacts with thiobarbituric acid
to produce a red colored complex that has peak absorbance at
532 nm. Brieﬂy, 3 ml phosphoric acid (1%) and 1 ml TBA (0.6%)
were added to 0.5 ml of homogenate in a centrifuge tube and the
mixture was heated for 45 min in a boiling water bath. After
cooling, 4 ml n-butanol was added to the mixture and vortex-
mixed for 1 min followed by centrifugation at 2000 rpm for
20 min. The colored layer was transferred to a fresh tube and
its absorbance was measured at 532 nm. MDA levels were
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determined using 1,1,3,3-tetramethoxypropane as standard. The
standard curve of MDA was constructed over the concentration
range of 0–10 μM (Naghizadeh et al., 2008).
2.6.2. Determination of glutathione peroxidase concentration
GSH-Px concentration was measured with the GSH peroxidase
kit (Randox Company, England) (Abdel-Salam et al., 2012).
2.6.3. Total thiol (–SH) groups assay
Total –SH groups were measured using DTNB (5,50-dithiobis-
2-nitrobenzoic acid) as the reagent (Kamboj et al., 2008). This
reagent reacts with the –SH groups to produce a yellow colored
complex which has a peak absorbance at 412 nm. Brieﬂy, 1 ml tris–
EDTA buffer (pH 8.6) was added to 50 μl brain homogenate in 2 ml
cuvettes and absorbance was read at 412 nm against tris–EDTA
buffer alone (A1). Then, 20 μl DTNB reagents (10 mM in methanol)
was added to the mixture and after 15 min (stored in laboratory
temperature), the sample absorbance was read again (A2). The
absorbance of DTNB reagent was also read as a blank (B). Total
thiol concentration (mM) was calculated from the following
equation:
Total thiol concentration ðmMÞ ¼ ðA2A1BÞ  1:07
0:05 13:6
2.7. Statistical analysis
Results were expressed as mean7S.E.M. The behavioral data of
learning in MWM test was analyzed by two-way analysis of
variance (ANOVA) followed by Bonferroni's post test. The bio-
chemical data and memory performance in MWM test were
analyzed by one-way ANOVA followed by Tukey's test. All analysis
was performed using the Prism 5.0 (San Diego, CA, USA) statistical
package program. Statistical signiﬁcance was ascertained at
Po0.05.
3. Results
3.1. Effects of GA against 2VO-induced learning and memory
impairment in MWM test
Fig. 1a shows the reduction of latency time to ﬁnd the hidden
platform in all groups during the four-day training trials in MWM
task. Analysis or the results revealed that 2VO animals presented a
higher latency time than sham group (Po0.001), showing poorer
learning performance due to PCH. But, chronic treatment with GA
signiﬁcantly improved the learning performance in 2VOþGA
group as compared to 2VO animals (Po0.01). Moreover, admin-
istration of GA per se in shamþGA group did not modify basal
learning performance of rats during 4 days of training as compared
to sham group (P40.05).
According to Fig. 1b, on the probe trial day with the platform
removed, rats in the 2VOþGA group failed to remember the
precise location of platform, spending less time in the target
quadrant than sham group (Po0.001). But, the time spending in
the target quadrant was signiﬁcantly increased with chronic
administration of GA as compared to 2VO group indicating
improved consolidation of memory (Po0.001). Moreover, admin-
istration of GA per se in shamþGA group did not affect the
parameter as compared to sham group (P40.05). Furthermore,
there was no signiﬁcant difference among the swim speeds of all
four groups (Fig. 1c, P40.05). This excludes the possibility that the
activity per semay have contributed to the severe deﬁcits in MWM
after 2VO surgery.
3.2. Effect of GA on MDA levels in the hippocampus and frontal
cortex
The degree of free radical damage following 2VO was assessed
using LPO, which measured as MDA levels. According to Fig. 2,
there was an increase in MDA levels in the hippocampus and
frontal cortex of 2VO group (Po0.001) as compared to sham
group. Oral administration of GA resulted in a signiﬁcant reduction
of MDA levels in the brain tissues of 2VOþGA animals as
Fig. 1. Effects of gallic acid (GA, 100 mg/kg/day, p.o., 10 days) on (a) escape latency
to ﬁnd the hidden platform, (b) percentage of time spent in target quadrant during
the probe trials and (c) swim speed in the Morris water maze test in 2-vessle
occlusion (2VO) rats. Data are expressed as mean7S.E.M. (n¼7). nnnPo0.05; 2VO
compared to sham group from ﬁrst day of the training sessions; ##Po0.01,
###Po0.001, 2VOþGA compared to 2VO group from ﬁrst day of the training
sessions.
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compared to 2VO group (Po0.001). GA per se did not inﬂuence the
MDA levels.
3.3. Effect of GA on GSH-Px activity in the hippocampus
and frontal cortex
GSH-Px concentration (μ/l) was measured to evaluate the
enzymatic defense potential of the cells against the oxidative
stress. According to Fig. 3, the GSH-Px concentration was signiﬁ-
cantly decreased in 2VO group as compared to sham group in both
hippocampus and frontal cortex (Po0.01, Po0.001; respectively).
However, the decrease of the GSH-Px concentration was signiﬁ-
cantly restored by GA treatment in the brain tissues of 2VOþGA
group (Po0.01, Po0.001; respectively). GA per se did not affect
the GSH-Px concentration.
3.4. Effect of GA on total thiol levels in the hippocampus
and frontal cortex
The total thiol concentration (mM) was measured to evaluate
the non-enzymatic defensive potential of the cell against oxidative
stress. According to Fig. 4, total thiol contents in 2VO animals were
found to be signiﬁcantly depleted as compared to sham group in
the hippocampus and the frontal cortex (Po0.001). Treatment
with GA in 2VOþGA group was able to raise total thiol contents
signiﬁcantly as compared to 2VO animals (Po0.01). GA per se did
not affect the total thiol levels.
4. Discussion
The present study intended to evaluate the neuroprotective
effect of gallic acid (GA), a natural polyphenolic compound, on the
permanent cerebral hypoperfusion (PCH) induced cognitive and
biochemical alterations in rats. PCH produced a marked impair-
ment in cognitive function, which was associated with signiﬁcant
increase in the oxidative stress in rat brain (Peng et al., 2007).
However, chronic treatment with GA signiﬁcantly alleviated the
cognitive dysfunction and restored oxidative stress markers in
cerebral hypoperfused rats.
The permanent occlusion of bilateral common carotid arteries
in rats is a common cerebral ischemic model to investigate
vascular dementia and drug effect on this disorder (Wang et al.,
2000). Oxidative stress has been suggested to play a key role in
hypoxic- ischemic brain damage and also correlates with expres-
sion of inﬂammatory proteins in the cerebral vasculature and
impairment of cognitive function (Evola et al., 2010). Reactive
oxygen species can oxidize membrane lipids, essential cellular
proteins, and DNA that cause cellular injury. Free radicals catalyze
the peroxidation of unsaturated fatty acids in cell membranes;
thus, generating MDA, a lipid peroxidation marker (Bilenko et al.,
1988; Akdag et al., 2010). In the present study, compared to those
in sham group, the MDA levels in GA-treated group signiﬁcantly
decreased, whereas the GSH and GSH-Px contents were preserved.
These ﬁndings are consistent with earlier reports showing that GA
might attenuate the excessive formation of reactive oxygen species
and compensate antioxidant ability secondary to oxidative insults.
It has been reported that GA exerted the protective effects against
amyloid β-mediated neurotoxicity (Bastianetto et al., 2006), lead
nitrate, streptozotocin, kainic acid and or 6-OHDA induced brain
oxidative damages (Prince et al., 2011; Reckziegel et al., 2011;
Huang et al., 2012; Mansouri et al., 2013a,b). Li et al. (2005)
showed that when GA was used to treat the 9-month-old male
senescence accelerated mice not only reinstated the activities of
CAT and GSH-Px but also signiﬁcantly reduced the amount of MDA
in the brain, liver and kidney. Also, pre-treatment of SH-SY5Y
human cells with GA and its derivatives suppressed 6-OHDA
induced oxidative stress in vitro to various degrees (Lu et al.,
2006). In addition to protective effects in neurotoxicity models, GA
counteracted the oxidative damage caused by lindane and carbon
tetrachloride in rat liver and kidney (Jadon et al., 2007; Padma et
al., 2011). Other researchers have also reported that antioxidants
could protect against cognitive deﬁcits induced by chronic cerebral
hypoperfusion. Azzubaidi et al. (2012) showed the protective effect
of black cumin seed on learning ability and memory in a rat model
of chronic cerebral hypoperfusion. Chrysin (5,7-dihydroxyﬂavone),
a ﬂavonoid in Passiﬂora caerulea, has therapeutic potential for
the treatment of neurodegeneration and dementia caused by
decreased cerebral blood ﬂow (He et al., 2012). In another study,
Z-ligustilide signiﬁcantly prevented hypoperfused cognitive deﬁ-
cits and brain damage through an antioxidant effect and by
improvement of cholinergic activity (Kuang et al., 2008). As shown
Fig. 2. Effect of GA on MDA levels in the hippocampus and frontal cortex of
2-vessle occlusion (2VO) rats. Values are expressed as mean7S.E.M (n¼7).
nnnPo0.001 as compared to sham group. ##Po0.01; ###Po0.001 as compared
to 2VO group.
Fig. 3. Effect of GA on GSH-Px concentration in the hippocampus and frontal cortex
of 2-vessle occlusion (2VO) rats. Values are expressed as mean7S.E.M (n¼7).
nnPo0.01, nnnPo0.001 as compared to sham group. #Po0.05; ##Po0.01; ###Po
0.001 as compared to 2VO group.
Fig. 4. Effect of GA on total thiol concentration in the hippocampus and frontal
cortex of 2-vessle occlusion (2VO) rats. Values are expressed as mean7S.E.M
(n¼7). nnnPo0.001 as compared to sham group; #Po0.05; ##Po0.01;
###Po0.001 as compared to 2VO group.
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in a study by Xu et al. (2010), green tea polyphenols, which are
potent antioxidants and free radical scavengers, can attenuate
vascular cognitive impairment. The ethanolic extract of saffron and
its active constituent, crocin, have also shown to exert protective
effect against PCH in rats (Hosseinzadeh et al., 2012). These studies
indicate that the antioxidant effects of these compounds play
an important role in improving the spatial cognitive abilities
after PCH.
Previous studies have demonstrated that central cholinergic
system is damaged by PCH in rats (Tanaka et al., 1996; Ni et al.,
1995) and stimulation of the above system improves spatial
memory deﬁcits in this animal model (Murakami et al., 1997).
Also, it has been reported that glutamate release in the brain was
increased following cerebral ischemia (Davalos et al., 2000). This
neurotransmitter is capable to generate reactive oxygen species
and induction of neural toxicity and death (Novelli et al., 1988).
Moreover, it is well-established that some drugs can improve the
learning and memory of patients with Alzheimer's disease or VD
by modulating classic neurotransmitters such as glutamate and
acetylcholine. Also, various medications such as antioxidants,
radical scavengers and calcium antagonists have been approved
for the treatment of VD around the world (Itil et al., 1998). It has
been demonstrated that GA can inhibit the elevation of glutamate
release, Ca2þ and reactive oxygen species generation and also has
anticholinesterase activity in the brain tissue. These effects of GA
could be associated with its neuroprotective properties (Ban et al.,
2008; Ghayur et al., 2011; Hong et al., 2012).
In conclusion, our data demonstrated that treatment with GA
could improve the cognitive deﬁcits and 2VO-induced cerebral
damages in rats. Cognitive enhancing and neuroprotective effect of
GA are associated with the anti-oxidant and partly at least anti-
cholinesterase and glutamate inhibiting activities of this com-
pound. However, the present results do not exclude the other
mechanisms involved in the gallic acid action. Further preclinical
studies are necessary to elucidate the mechanism(s) of action of
this compound including modulation of the cholinergic and
glutamatergic neurotransmission. Altogether, these ﬁndings may
provide pharmacological basis for the use of GA as an antioxidant
metabolite of ellagitannins in the treatment and prevention of
neurodegenerative diseases such as vascular dementia and could
explain the protective effects of ellagitannin consumed from
natural sources.
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